FDA Warns Consumers Against Using Smelling Salts and Inhalants

The cited products, which claim to boost alertness and energy, contain ammonia, which can cause coughing, airway constriction, and eye and nose irritation.

The Food and Drug Administration (FDA) headquarters in White Oak, Md. on Aug. 29, 2020. REUTERS/Andrew Kelly

The U.S. Food and Drug Administration (FDA) issued a warning this week advising American consumers against using certain inhalant products marketed to promote alertness and boost energy.

These inhalants such as smelling salts, which primarily contain ammonia, are not approved by the FDA and pose significant health risks, according to the alert from the agency issued on Aug. 6.